TY  - JOUR

T1  - Temporary 2-week suspension of methotrexate treatment to enhance COVID-19 vaccine response in people with immune-mediated inflammatory diseases: the VROOM RCT

JO  - Efficacy and Mechanism Evaluation

UR  - https://eprints.whiterose.ac.uk/id/eprint/226650

PY  - 2025/04/30

AU  - Abhishek A

AU  - Peckham N

AU  - Pade C

AU  - Gibbons JM

AU  - Cureton L

AU  - Reynolds CJ

AU  - Francis A

AU  - Barber V

AU  - Williams J

AU  - Appelbe D

AU  - Eldridge L et al

ED  - 

DO  - DOI: 10.3310/kytk6537

PB  - National Institute for Health and Care Research

Y2  - 2025/11/25

ER  -